Sign in

CIK 0001576280

  • Large accelerated filer

Guardant Health, Inc.

Sign in to watch
Ticker
GH
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
454139254
Phone
+1 855-698-8887
Business address
3100 HANOVER STREET, PALO ALTO, CA, 94304
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$9,748,620
in 10 filings, $223K under 10b5-1 plans

Net −$9,748,620. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-22 POTTER MYRTLE S Director Sale 10b5-1 −1,556 $131.16 $204K 20,971
2026-06-17 POTTER MYRTLE S Director Exercise or conversion +4,203 22,527
2026-06-17 POTTER MYRTLE S Director Exercise or conversion · Restricted Stock Units −4,203 0
2026-06-17 POTTER MYRTLE S Director Grant or award · Restricted Stock Units +2,711 2,711
2025-10-17 POTTER MYRTLE S Director Sale 10b5-1 −26 $66.95 $2K 18,324
2025-10-15 POTTER MYRTLE S Director Exercise or conversion +69 18,350
2025-10-15 POTTER MYRTLE S Director Exercise or conversion · Restricted Stock Units −69 0
2025-09-17 POTTER MYRTLE S Director Sale 10b5-1 −26 $55.63 $1K 18,281
2025-09-15 POTTER MYRTLE S Director Exercise or conversion 10b5-1 +68 18,307
2025-09-15 POTTER MYRTLE S Director Exercise or conversion · Restricted Stock Units 10b5-1 −68 69

Page 1 of 1 · 10 trades